For HCPsIntended for HCPs.
All Authors
MP

Oncology

Dr. Meera Pillai

Recent Articles

18 total

Oncology

WHO Updates Guidelines on BRCA Testing for Breast and Ovarian Cancer Screening

WHO updates BRCA testing guidelines for breast and ovarian cancer: key recommendations for screening high-risk populations.

Apr 30, 2026|3 min read|WHO

Oncology

Intismeran Autogene Reduces Melanoma Recurrence by 49% at 5 Years

Intismeran autogene reduces melanoma recurrence by 49% at five years, offering new hope for high-risk patients, as shown in KEYNOTE-942 trial.

Apr 25, 2026|3 min read|NEJM

Medical Research

Remote Monitoring Cuts Cancer Surgery Recovery Time

Discover how remote perioperative monitoring improves outcomes for cancer surgery patients, reducing recovery time and enhancing care.

Apr 24, 2026|4 min read|Medical Xpress

Oncology

Talotrectinib Receives FDA Approval for ROS1-Positive Non-Small-Cell Lung Cancer

Talotrectinib approved by FDA for ROS1-positive NSCLC, providing new hope for patients facing limited treatment options.

Apr 24, 2026|3 min read|NEJM

Oncology

Targeting TMOD2 to Halt Colorectal Cancer Spread

Discover the crucial role of TMOD2 in colorectal cancer progression and metastasis, and how understanding its mechanisms can inform targeted treatment strategies for improved patie...

Apr 23, 2026|6 min read|British Journal of Cancer

Oncology

Lipid Levels Linked to 30% Lower Lymphoma Risk

Discover how abnormal lipid levels impact lymphoid malignancy risk in a study of 403,625 UK Biobank participants with 10.5 years of follow-up.

Apr 23, 2026|2 min read|British Journal of Cancer

Oncology

ctDNA Guides Surgery for Recurrence

Learn how circulating tumor DNA can predict metastases and inform surgical decisions for better patient outcomes in oncology.

Apr 22, 2026|2 min read|Cancer Network

Oncology

82% Complete Response in BCG-Unresponsive NMIBC

Discover a new treatment option for high-risk BCG-unresponsive NMIBC, offering a complete response in 82% of patients and potentially reducing cystectomy rates.

Apr 15, 2026|8 min read|Cancer Network

Oncology

Detect MSI in CRC with 1-Hour Molecular Test

Quickly identify microsatellite instability-high colorectal cancer with a rapid molecular test, guiding targeted therapy decisions for patients.

Apr 15, 2026|3 min read|Cancer Network

Oncology

Similar Survival in ES-SCLC with Cis/Carbo Plus Etoposide

Real-world analysis shows comparable efficacy between cisplatin and carboplatin with etoposide in extensive-stage small cell lung cancer treatment.

Apr 15, 2026|4 min read|Cancer Network

Oncology

Improve Patient Outcomes with Early Palliative Care

Learn how early palliative care integration can enhance patient quality of life and reduce unnecessary hospitalizations in oncology practices

Apr 15, 2026|3 min read|Cancer Network

Medical Research

T Cell Exclusion Mechanisms in B Cell Lymphomas

Discover how ATR-dependent determinants exclude T cells from germinal center dark zones in aggressive B cell lymphomas, shedding light on lymphoma biology and potential therapeutic...

Apr 13, 2026|63 min read|Journal of Clinical Investigation